Cytokinetics, Incorporated (CYTK) vs Oscar Health, Inc. (OSCR)

A side-by-side comparison of Cytokinetics, Incorporated and Oscar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CYTK vs OSCR

growth of $100 · dividends reinvested · last 6y
CYTK +234.8% (+22.3%/yr)OSCR -6.8% (-1.2%/yr)CYTK compounded faster over this window
0200400600Start $10020222023202420252026$335$93
CYTK OSCR

CYTK vs OSCR: by the numbers

  • •OSCR is the larger company ($8.39B vs $7.65B market cap).
  • •OSCR is profitable (3.60% net margin) while CYTK runs a net loss (-1259.87%).
  • •OSCR grew revenue faster over the past five years (64.83% vs 4.19% CAGR).

Metrics side by side

Valuation

MetricCYTKOSCR
P/E ratioN/A23.12
Forward P/EN/A16.96
P/S ratio107.780.55
P/B ratioN/A4.09
EV / EBITDAN/A7.28
FCF yieldN/A51.65%

Profitability

MetricCYTKOSCR
Gross margin84.97%14.38%
Operating margin-695.44%4.07%
Net margin-1259.87%3.60%
ROEN/A26.84%
ROIC-39.80%22.98%

Growth (annualized)

MetricCYTKOSCR
Revenue CAGR (5Y)4.19%64.83%
FCF CAGR (5Y)N/A80.81%
Total return CAGR (5Y)11.24%14.97%

Frequently asked

Which has grown faster, CYTK or OSCR?
Over the past five years, OSCR grew revenue faster — CYTK at a 4.19% CAGR versus OSCR at 64.83%.
Is CYTK or OSCR more profitable?
OSCR runs the higher net margin — CYTK at -1259.87% versus OSCR at 3.60%.
How have CYTK and OSCR total returns compared?
Over the past 5 years, CYTK delivered 11.24% and OSCR delivered 14.97% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.